Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Non-nicotinic therapies for smoking cessation.

Siu EC, Tyndale RF.

Annu Rev Pharmacol Toxicol. 2007;47:541-64. Review.

PMID:
17209799
2.

The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation.

Escobar-Chávez JJ, Merino V, López-Cervantes M, Rodríguez-Cruz IM, Quintanar-Guerrero D, Ganem-Quintanar A.

Curr Drug Discov Technol. 2009 Sep;6(3):171-85. Epub 2009 Sep 1. Review.

PMID:
19496753
3.

Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Cahill K, Stevens S, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2013 May 31;(5):CD009329. doi: 10.1002/14651858.CD009329.pub2. Review.

PMID:
23728690
4.

Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.

King DP, Paciga S, Pickering E, Benowitz NL, Bierut LJ, Conti DV, Kaprio J, Lerman C, Park PW.

Neuropsychopharmacology. 2012 Feb;37(3):641-50. doi: 10.1038/npp.2011.232. Epub 2011 Nov 2.

5.
6.

[Current and future medical drugs for smoking cessation].

Kusma B, Mache S, Deissenrieder F, Quarcoo D, Welte T, Groneberg D.

Laryngorhinootologie. 2009 Jun;88(6):410-9; quiz 420-2. doi: 10.1055/s-0029-1220929. Epub 2009 Jun 5. German.

PMID:
19504411
7.

Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring.

Maritz GS.

Ther Adv Respir Dis. 2009 Aug;3(4):193-210. doi: 10.1177/1753465809343712. Epub 2009 Aug 25. Review.

PMID:
19706643
8.
9.

Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.

Bailey SR, Crew EE, Riske EC, Ammerman S, Robinson TN, Killen JD.

Paediatr Drugs. 2012 Apr 1;14(2):91-108. doi: 10.2165/11594370-000000000-00000. Review.

10.

Smoking cessation.

Rennard SI, Daughton DM.

Clin Chest Med. 2014 Mar;35(1):165-76. doi: 10.1016/j.ccm.2013.11.002. Review.

PMID:
24507844
11.

Varenicline: for smoking cessation.

Rao J, Shankar PK.

Kathmandu Univ Med J (KUMJ). 2009 Apr-Jun;7(26):162-4. Review.

PMID:
20071853
12.

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR; Varenicline Phase 3 Study Group.

JAMA. 2006 Jul 5;296(1):56-63. Erratum in: JAMA. 2006 Sep 20;296(11):1355.

PMID:
16820547
13.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
14.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
15.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
16.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
17.

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group.

JAMA. 2006 Jul 5;296(1):47-55.

PMID:
16820546
18.

[Drug of the month. Varenicline (Champix)].

Vandemergel X.

Rev Med Liege. 2007 Feb;62(2):122-4. French.

PMID:
17461303
19.

The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician.

Crane R.

Prim Care. 2007 Mar;34(1):117-35. Review. No abstract available.

PMID:
17481990
20.

Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.

Lutz MA, Lovato P, Cuesta G.

Hosp Pract (1995). 2012 Feb;40(1):35-43. doi: 10.3810/hp.2012.02.946.

PMID:
22406881

Supplemental Content

Support Center